February saw the then National Institute for Clinical Excellence (NICE) announce plans to develop clinical guidelines on the diagnosis and treatment of CFS/M.E.
Tony Wright MP, Chair of the All Party Parliamentary Group (APPG) on M.E., led a debate in the Commons about common benefits problems faced by people with M.E.
In the summer, CEO Chris Clark issued a statement explaining explaining Action for M.E.'s postion on the PACE trial.
